Catalina D Alba-Soto

5PUBLICATIONS
29CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 28, 2026
Integrated In Vitro and In Silico Profiling of Piperazinyl Thiosemicarbazone Derivatives Against Trypanosoma cruzi: Stage-Specific Activity and Enzyme Inhibition.

Héctor A Baldoni, María L Sbaraglini, Darío E Balcazar

|Dec 31, 2025
Application of Data-Centric Supervised Machine Learning to Predict Phenotypic Activity Against Clinically Relevant Stages of Trypanosoma cruzi.

Nicolás Pérez-Mauad, Lucas N Alberca, Alejandra C Schoijet

|Aug 03, 2023
Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies.

Giuliana Muraca, María Esperanza Ruiz, Rocío C Gambaro

|Dec 09, 2022
A combined ligand and target-based virtual screening strategy to repurpose drugs as putrescine uptake inhibitors with trypanocidal activity.

Manuel A Llanos, Lucas N Alberca, María D Ruiz

|Oct 30, 2018
IL-10 participates in the expansion and functional activation of CD8+ T cells during acute infection with Trypanosoma cruzi.

Agustina M Pino-Martínez, Cristian G Miranda, Estela I Batalla

Pageof 1

Frequent Collaborators

3 joint publications

María Laura Sbaraglini

3 joint publications

Alan Talevi

2 joint publications

Giuliana Muraca

1 joint publications

María Esperanza Ruiz